Postdoctoral Training in the Radiation Sciences

放射科学博士后培训

• 批准号: 7233332
• 负责人: Amato J. Giaccia
• 金额: $ 10.94万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-01 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7233332
• 关键词: Radiation; Science; post-doctoral training

DESCRIPTION (provided by applicant): The training of academic radiation oncologists and biologists has suffered nationwide from the paucity of formalized training programs. In this application we propose to bring together faculty associated with all three radiation oncology subspecialties (medicine, biology and physics) to establish an interdisciplinary postgraduate training program in radiation sciences. This two year program will accept two exceptional postdoctoral fellows and/or medical residents per year who are interested in an intensive research-based program. The goals of the training program are 1) To teach the trainees the theory concerning the physics governing the delivery of radiation, and the cellular biology governing its biologic effect. 2) To educate participants in the design and execution of cutting edge research in the radiation sciences. And 3) To gather together trainees from the fields of medicine, biology and physics so that they may develop a mutual appreciation for the many aspects of the study and treatment of patients with cancer. This is a particularly timely and relevant application because therapeutic radiation has become a mainstay in the treatment of many forms cancer. It is therefore imperative to develop a well trained cohort of professionals who will be responsible for the next generation of therapeutic advancements.

描述（由申请人提供）：由于缺乏正式的培训计划，学术放射肿瘤学家和生物学家的培训在全国范围内受到了影响。在此申请中，我们建议将与所有三个放射肿瘤学子专业（医学、生物学和物理学）相关的教师聚集在一起，建立放射科学的跨学科研究生培训计划。这个为期两年的项目每年将接受两名对深入研究项目感兴趣的杰出博士后研究员和/或住院医生。培训计划的目标是 1) 向学员传授有关控制辐射传递的物理学和控制其生物效应的细胞生物学的理论。 2) 教育参与者设计和执行辐射科学前沿研究。 3) 将来自医学、生物学和物理学领域的学员聚集在一起，以便他们能够对癌症患者的研究和治疗的许多方面形成相互欣赏。这是一个特别及时和相关的应用，因为放射治疗已成为治疗多种癌症的主要手段。因此，必须培养一支训练有素的专业人员队伍，他们将负责下一代治疗的进步。